Literature DB >> 12376501

Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential?

Libby M Morimoto1, Polly A Newcomb, Cornelia M Ulrich, Roberd M Bostick, Cynthia J Lais, John D Potter.   

Abstract

Recent studies have suggested that hyperplastic polyps may be benign precursor lesions for a distinct subset of colorectal tumors. We conducted a clinic-based case-control study to evaluate risk factors for hyperplastic polyps. Cases with hyperplastic polyps (n = 219), adenomas (n = 437), and both types of polyps (n = 138), along with colonoscopy-negative controls (n = 708), were identified at a gastroenterology practice in the Minneapolis area during 1991-1994. A self-administered questionnaire was used to collect risk factor information. Risk factors for hyperplastic and adenomatous polyps were generally similar to those for colorectal cancer. Male sex, smoking, and alcohol consumption were associated with increased risk of all polyp groups; nonsteroidal anti-inflammatory drug use, hormone replacement therapy use, and calcium intake were associated with reduced risk. There was no apparent association between increasing age and hyperplastic polyp risk (P = 0.21) in this analysis, although it was a strong risk factor for adenoma (P < 0.001). The odds ratio (OR) for hyperplastic polyps associated with >25 pack-years of smoking was 4.1 [95% confidence interval (CI), 2.2-7.6], whereas the OR for adenoma alone was 1.3 (95% CI, 0.8-2.3). The OR estimate for individuals diagnosed with both polyp types was 4.2 (95% CI, 1.9-9.3). These results suggest, as one possibility, that the consistent association of adenoma and smoking observed in previous studies may be partially attributable to the inclusion of individuals with both adenomas and hyperplastic polyps in the adenoma case group. To the contrary, individuals with both polyp types may be expressing a phenotype distinct from those who have only adenomas and should be considered separately. Further studies are necessary to establish which polyp phenotypes are related to smoking. Overall, the similarity of the risk profiles of colorectal hyperplastic polyps, adenoma, and cancer provides additional support for the growing body of evidence that some hyperplastic polyps may have neoplastic potential.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12376501

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  74 in total

1.  Prevalence of colorectal polyps in pediatric colonoscopy.

Authors:  Kalpesh Thakkar; Abeer Alsarraj; Emily Fong; Jennifer L Holub; Mark A Gilger; Hashem B El Serag
Journal:  Dig Dis Sci       Date:  2011-12-07       Impact factor: 3.199

2.  Body mass, tobacco smoking, alcohol drinking and risk of cancer of the small intestine--a pooled analysis of over 500,000 subjects in the Asia Cohort Consortium.

Authors:  P Boffetta; W D Hazelton; Y Chen; R Sinha; M Inoue; Y T Gao; W P Koh; X O Shu; E J Grant; I Tsuji; Y Nishino; S L You; K Y Yoo; J M Yuan; J Kim; S Tsugane; G Yang; R Wang; Y B Xiang; K Ozasa; M Nagai; M Kakizaki; C J Chen; S K Park; A Shin; H Ahsan; C X Qu; J E Lee; M Thornquist; B Rolland; Z Feng; W Zheng; J D Potter
Journal:  Ann Oncol       Date:  2011-12-06       Impact factor: 32.976

3.  Cancer: Subsite differences in colorectal cancer--anything new?

Authors:  John D Potter
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-05       Impact factor: 46.802

4.  Virtual colonoscopy vs optical colonoscopy.

Authors:  Zhengrong Liang; Robert Richards
Journal:  Expert Opin Med Diagn       Date:  2010-03-01

5.  Menopausal hormone therapy and risks of colorectal adenomas and cancers in the French E3N prospective cohort: true associations or bias?

Authors:  Sophie Morois; Agnès Fournier; Françoise Clavel-Chapelon; Sylvie Mesrine; Marie-Christine Boutron-Ruault
Journal:  Eur J Epidemiol       Date:  2012-05-29       Impact factor: 8.082

6.  Dietary intake of PUFAs and colorectal polyp risk.

Authors:  Harvey J Murff; Martha J Shrubsole; Qiuyin Cai; Walter E Smalley; Qi Dai; Ginger L Milne; Reid M Ness; Wei Zheng
Journal:  Am J Clin Nutr       Date:  2012-01-25       Impact factor: 7.045

7.  C-reactive protein genotypes and haplotypes, polymorphisms in NSAID-metabolizing enzymes, and risk of colorectal polyps.

Authors:  Elizabeth M Poole; Jeannette Bigler; John Whitton; Justin G Sibert; John D Potter; Cornelia M Ulrich
Journal:  Pharmacogenet Genomics       Date:  2009-02       Impact factor: 2.089

8.  TGFB1 509 C/T polymorphism and colorectal cancer risk: a meta-analysis.

Authors:  Fang Fang; Long Yu; Yang Zhong; Lei Yao
Journal:  Med Oncol       Date:  2009-12-10       Impact factor: 3.064

9.  Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways.

Authors:  Martha L Slattery; Roger K Wolff; Karen Curtin; Frank Fitzpatrick; Jennifer Herrick; John D Potter; Bette J Caan; Wade S Samowitz
Journal:  Mutat Res       Date:  2008-10-15       Impact factor: 2.433

10.  Differences in epidemiologic risk factors for colorectal adenomas and serrated polyps by lesion severity and anatomical site.

Authors:  Andrea N Burnett-Hartman; Michael N Passarelli; Scott V Adams; Melissa P Upton; Lee-Ching Zhu; John D Potter; Polly A Newcomb
Journal:  Am J Epidemiol       Date:  2013-03-03       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.